Immune-Onc Therapeutics' Series B Round

Immune-Onc Therapeutics raised a round of funding on September 18, 2018.

Immune-Onc Therapeutics is a privately held cancer immunotherapy company dedicated to the discovery and development of biologic treatments for cancer patients. The company aims to translate scientific…

Articles about Immune-Onc Therapeutics' Series B Round: